Table 1. Characteristics of the coronavirus disease (COVID-19) articles/studies included in the scoping review, 10 January–6 February 2020 (n = 249).
| Characteristic | Number of articles/studies | Percentage (%) | |
|---|---|---|---|
| Publication platform | Journal | 192 | 77.1 |
| Other than journala | 57 | 22.9 | |
| Journal (n = 192) | The Lancet | 13 | 6.8 |
| Journal of Medical Virology | 12 | 6.3 | |
| New Medicine | 9 | 4.7 | |
| The New England Journal of Medicine | 9 | 4.7 | |
| Eurosurveillance | 8 | 4.2 | |
| Journal of Traditional Chinese Medicine | 7 | 3.6 | |
| British Medical Journal (BMJ) | 7 | 3.6 | |
| Radiology | 5 | 2.6 | |
| Travel Medicine and Infectious Disease | 5 | 2.6 | |
| Chinese Nursing Research | 5 | 2.6 | |
| Chinese Journal of Tuberculosis and Respiration | 4 | 2.1 | |
| Nature | 4 | 2.1 | |
| Chinese Journal of Contemporary Paediatrics | 3 | 1.6 | |
| Emerging Microbes and Infections | 3 | 1.6 | |
| The Journal of the American Medical Association (JAMA) | 3 | 1.6 | |
| Journal of Hospital Infection | 3 | 1.6 | |
| Journal of Travel Medicine | 3 | 1.6 | |
| Herald of Medicine | 3 | 1.6 | |
| Chinese Journal of Emergency Medicine | 3 | 1.6 | |
| Chinese Journal of Paediatrics | 3 | 1.6 | |
| Other | 80 | 41.7 | |
| First author’s country or international organisation | China | 147 | 59.0 |
| United States | 33 | 13.3 | |
| United Kingdom | 16 | 6.4 | |
| WHO | 10 | 4.0 | |
| Canada | 7 | 2.8 | |
| Germany | 6 | 2.4 | |
| Other | 30 | 12.1 | |
| Publication or posted date | 10–15 Jan | 6 | 2.4 |
| 16–20 Jan | 7 | 2.8 | |
| 21–25 Jan | 38 | 15.3 | |
| 26–31 Jan | 93 | 37.3 | |
| 1–6 Feb | 105 | 42.2 | |
| Type of article/study | Guidance/guideline or consensus statement | 56 | 22.6 |
| Review | 39 | 15.7 | |
| Basic research | 35 | 14.1 | |
| Letter | 25 | 10.0 | |
| Epidemiological studyb | 22 | 8.8 | |
| Editorial | 20 | 8.0 | |
| Comments | 11 | 4.4 | |
| News item | 9 | 3.6 | |
| Case report | 9 | 3.6 | |
| Cross-sectional study | 7 | 2.8 | |
| Case series | 5 | 2.0 | |
| Other | 11 | 4.4 | |
| Topic | Prevention and control | 33 | 13.3 |
| Outbreak reporting | 30 | 12.0 | |
| Genetics | 22 | 8.8 | |
| Transmissibility | 22 | 8.8 | |
| Clinical features | 21 | 8.4 | |
| Diagnosis and treatment | 19 | 7.6 | |
| Molecular biology | 15 | 6.0 | |
| Management | 14 | 5.6 | |
| Characteristics of SARS-CoV-2c | 11 | 4.4 | |
| Drug-relatedd | 8 | 3.2 | |
| Traditional Chinese medicine | 8 | 3.2 | |
| Lessons and challenges | 7 | 2.8 | |
| Transmission pattern | 7 | 2.8 | |
| Surveillance and screening | 5 | 2.0 | |
| Mental health | 4 | 1.6 | |
| Other | 23 | 9.2 | |
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; WHO: World Health Organization.
a Includes the websites of WHO, United States Centers for Disease Control and Prevention (US CDC), European Centre for Disease Prevention and Control (ECDC) and Public Heath England (PHE), and preprint servers.
b Other than cross-sectional studies.
c Includes reviews and correspondence that discussed the characteristics of the virus in general.
d Other than traditional Chinese medicine.